| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |